Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Yabao Pharmaceutical Group Co. Ltd

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Yabao Pharmaceutical Co., Ltd. Beijing

    02 2Yabao Pharmaceutical Group Co., Ltd

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    ASCO GU
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ASCO GU
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2025-01-24

    Yabao Pharmaceutical Group Co. Ltd

    City : Yuncheng

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2025-01-24

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    ASCO GU
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ASCO GU
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2022-04-20

    Yabao Pharmaceutical Group Co. Ltd

    City : Tongzhou

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2022-04-20

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    ASCO GU
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ASCO GU
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2016-09-09

    Yabao Pharmaceutical Group Co. Ltd

    City : Yuncheng

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2016-09-09

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    ASCO GU
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ASCO GU
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-04-03

    Yabao Pharmaceutical Group Co. Ltd

    City : Tongzhou

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2015-04-03

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    ASCO GU
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ASCO GU
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-08-16

    Yabao Pharmaceutical Group Co. Ltd

    City : Tongzhou

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-08-16

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Yabao Pharmaceutical Group Co. Ltd and get a quotation

    Yabao Pharmaceutical Group Co. Ltd is a supplier offers 8 products (APIs, Excipients or Intermediates).

    Find a price of Dipyridamole bulk with JDMF offered by Yabao Pharmaceutical Group Co. Ltd

    Find a price of Dabigatran Etexilate Mesylate bulk with DMF offered by Yabao Pharmaceutical Group Co. Ltd

    Find a price of Dimethyl Fumarate bulk with DMF offered by Yabao Pharmaceutical Group Co. Ltd

    Find a price of Gefitinib bulk with DMF offered by Yabao Pharmaceutical Group Co. Ltd

    Find a price of Iron Sucrose bulk with DMF offered by Yabao Pharmaceutical Group Co. Ltd

    Find a price of Promestriene bulk with DMF offered by Yabao Pharmaceutical Group Co. Ltd

    Find a price of Sorafenib bulk with DMF offered by Yabao Pharmaceutical Group Co. Ltd

    Find a price of Tofacitinib Citrate bulk with DMF offered by Yabao Pharmaceutical Group Co. Ltd

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.